Updated 2 October 2026 · Aurelis Peptides
Tirzepatide is known for weight management and blood-sugar control. It acts on two body signals involved in appetite and insulin response. Specific prescription medicines contain tirzepatide; the Aurelis catalogue entry is a separate research material.
The human studies give these topics concrete results, rather than a general description of metabolism.
| Main interest | Weight loss, appetite and blood sugar |
|---|---|
| What studies looked at | Weight change and longer-term blood-sugar levels |
| Study context | Human clinical trials using defined formulations |
| Listed content | 30 mg / 40 mg / 50 mg / 60 mg per unit |
What benefits did the human studies find?
- Weight loss: SURMOUNT-1 found greater weight reduction than placebo over 72 weeks in adults with obesity or overweight, without diabetes.
- Blood sugar: SURPASS-2 found greater improvement in longer-term blood-sugar levels than semaglutide in adults with type 2 diabetes over 40 weeks.
- Appetite: a six-week trial in adults with overweight or obesity found lower food intake, hunger and cravings than placebo.
Weight-loss trial · Blood-sugar trial · Appetite study.
How does tirzepatide work?
The two signals are called GIP and GLP-1. Tirzepatide activates both. Its original discovery work investigated insulin release and the two-target action. Read the original research.
This is one peptide with two targets. Retatrutide has a third target, glucagon, giving it a different research profile.
Explore the listed strengths
Aurelis lists Tirzepatide 30 mg, 40 mg, 50 mg and 60 mg content per unit. Choose the listed content for your enquiry and ask about the available presentation.
Explore Tirzepatide with Aurelis
Open the Tirzepatide profile to compare listed content and send a product enquiry. Our team can discuss the presentation, local availability and batch documents.
Aurelis holds stock in Australia, Canada and the USA. Tell us your destination so our team can check local availability.
Enquire about Tirzepatide · Open the Tirzepatide catalogue profile